Current Grantees
Learn about the OCRA grantees creating a brighter future for everyone touched by ovarian and related gynecologic cancers.
Support Cancer Research Funding: Sponsor a Scientist
Sponsor a Scientist
Funding OCRA’s scientific research initiatives is one of the most powerful ways to support our life-saving work.
Contribute to Groundbreaking Research
Our Partners in Science program allows you to directly contribute to groundbreaking research aimed at preventing ovarian and related gynecologic cancers, developing better, more effective treatments, and ultimately finding a cure.
Program Details
The OCRA Partners in Science program offers donors a unique opportunity to sponsor specific scientists based on personalized criteria, fostering a meaningful connection between donors and researchers. The minimum contribution is $20,000.
-
Donors choose scientists to sponsor based on factors like geographic location, institution, or area of study. Sponsored researchers are selected from projects reviewed and approved annually by OCRA’s Scientific Advisory Committee (SAC).
-
Donors can review detailed grant information, including project summaries, abstracts, or full proposals. There’s ongoing communication between donors and researchers, with possibilities for personalized lab tours. Donors also receive regular updates on research progress, final summaries, annual reports, and publications resulting from the research.
-
Donors can sponsor multiple investigators depending on the contribution amount or co-sponsor a research project with others.
-
The program is open to individual donors, private family foundations, organizations, community events, and groups of friends or relatives supporting research on behalf of a loved one. OCRA staff provide guidance throughout the selection process, ensuring a meaningful and personal experience.
-
Donors’ support is acknowledged on the OCRA website, and grants can be named in honor or in memory of a loved one.
Partners in Science Donors
We are immensely grateful to the donors who sponsor our gifted scientists. WIthout their generosity, this program would not be possible.
Become a Partner in Science
To learn more about becoming an OCRA Partner in Science, please contact Jon Zeidman, Chief Development Officer, at jzeidman@ocrahope.org or 212-268-1002.
Related Topics
OCRA Sponsors NCCN Guidelines for Cervical, Ovarian, and Uterine Cancer Patients
This article was updated in April 2026 to reflect NCCN’s release of the 2026 Guidelines for Uterine Cancer Patients. OCRA is a proud sponsor of the 2026 Patient Guidelines for Cervical Cancer and Uterine Cancer, and the 2025 Patient Guidelines for Ovarian. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful … Continued
FDA Approves Lifyorli Plus Abraxane for Platinum-Resistant Ovarian Cancer
On March 25, 2026, the U.S. Food and Drug Administration (FDA) approved Lifyorli (relacorilant), made by Corcept Therapeutics, in combination with Abraxane (nab-paclitaxel) for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior lines of treatment, including prior Avastin (bevacizumab). The approval follows last month’s FDA … Continued
The Overview: March 2026
OCRA’s Annual Advocacy Day Draws Survivors and Caregivers from Across the Country More than 120 gynecologic cancer survivors, caregivers, researchers and supporters from nearly forty states filled the halls of the U.S. Capitol on Tuesday, March 17—dressed in teal, the color of ovarian cancer awareness—as Ovarian Cancer Research Alliance (OCRA) held its annual Spring Advocacy Day. The … Continued